Demand for acrylamide in USA is projected to grow from USD 1.5 billion in 2026 to USD 2.2 billion by 2036, expanding at a CAGR of 3.9%. N-methylolacrylamide and other monomers account for 61.0% share in 2026 within the derivative segment. Cationic acrylamide represents 42.0% share in 2026 within the ionic-type segment.